Association of Premedication before Blood Transfusion with Transfusion Reactions in Mohammad Hoesin Hospital Palembang
DOI:
https://doi.org/10.36408/mhjcm.v12i3.1363Keywords:
pre-transfusion premedication, transfusion reaction, blood transfusionAbstract
BACKGROUND: Premedication before blood transfusion is frequently used in clinical settings, albeit its effectiveness has not been shown. Premedication is used to stop transfusion-related fever and allergy. Unwanted or unanticipated consequences connected to the administration of unstable blood products are known as transfusion reactions.
AIMS: The aim of this study is to find out the association of premedication before blood transfusion with transfusion reactions.
METHOD: This study is an observational analytic study with cross-sectional design, the data obtained from Mohammad Hoesin Hospital Palembang from January 1st, 2020 to December 31st, 2021.
RESULT: 43 patients out of 73 samples did not receive premedication before the transfusion procedure, 8 patients (18.6%) experienced transfusion reactions, and 35 patients (81.4%) did not. 35 patients who received premedication, 2 patients (5.7%) experienced transfusion reactions, and 33 patients (94.3%) did not. The incidence of transfusion reactions at Mohammad Hoesin Hospital Palembang in the 2020–2021 period was not significantly associated with pre-transfusion premedication (p = 0.171). It is also not associated with blood transfusion history (p = 0.426), blood components (p = 0.793), or gender (p = 1.000).
CONCLUSION: Based on this finding, there is no significant association between premedication before blood transfusion and the transfusion reactions during period of 2020-2021 at Mohammad Hoesin Hospital Palembang.
Downloads
References
1. Ackfeld T, Schmutz T, Guechi Y, Le Terrier C. Blood transfusion reactions—a comprehensive review of the literature including a Swiss perspective. J Clin Med. 2022;11(10):2859.
2. Suddock JT, Crookston KP. Transfusion reactions. In: StatPearls. StatPearls Publishing; 2023.
3. Abdallah R, Rai H, Panch SR. Transfusion reactions and adverse events. Clin Lab Med. 2021;41(4):669–96.
4. Aggarwal P, Calderon Martinez E, Quijano Avalos EB. An overview of the identification, prevention, and management of immunological reactions to blood transfusion. J Cardiol Cardiovasc Ther. 2023;18:1–8.
5. Yao C-Y, Chien J-H, Chuang H-Y, Ho T-F. Associated factors with acute transfusion reaction from hospital online reporting events: A retrospective cohort study. J Patient Saf. 2020;16(4):e303–9.
6. Swissmedic. Haemovigilance Annual Report 2020. Bulter R, Dogan N, editors. Switzerland: Swiss Agency for Therapeutic Products; 2021. 1–27 p.
7. Berg P, Heiden M, Müller S, Meyer B, Witzenhausen C, Ruppert‐Seipp G, et al. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data. Vox Sang. 2024;119(9):953–62.
8. Lim MY, Pagano MB, Metcalf RA. Things we do for no reasonTM: routinely prescribing transfusion premedication to prevent acute transfusion reactions. J Hosp Med. 2020;15(11):684–6.
9. Grant AM, Wright FA, O’Brien TA. Rationalised premedication practice for blood product transfusions: A single‐centre quality initiative. J Paediatr Child Health. 2022;58(2):267–73.
10. Hole A, Budhai A, King K, Borge Jr PD. Decreasing Premedication for Blood Transfusions: A Quality Improvement Project. AJN Am J Nurs. 2024;124(8):34–41.
11. Sitthi-Amorn J, Denton E, Harper E, Carias D, Hashmi S, Bami S, et al. Improving blood product transfusion premedication plan documentation: a single-institution quality improvement effort. Pediatr Qual Saf. 2022;7(3):e572.
12. Rujkijyanont P, Monsereenusorn C, Manoonphol P, Traivaree C. Efficacy of oral acetaminophen and intravenous chlorpheniramine maleate versus placebo to prevent red cell transfusion reactions in children and adolescent with thalassemia: a prospective, randomized, double‐blind controlled trial. Anemia. 2018;2018(1):9492303.
13. Yu Y, Lee T, Ho C, Lin H, Chen W, Chang C. The abrogated role of premedication in the prevention of transfusion‐associated adverse reactions in outpatients receiving leukocyte‐reduced blood components. Vox Sang. 2022;117(10):1179–86.
14. Purwati D, Rofinda ZD, Husni H. Karakteristik pasien transfusi darah dengan inkompatibilitas crossmatch di UTD RSUP Dr. M. Djamil Padang. J Kesehat Andalas. 2020;9(3):308–12.
15. Kohorst MA, Khazal SJ, Tewari P, Petropoulos D, Mescher B, Wang J, et al. Transfusion reactions in pediatric and adolescent young adult haematology oncology and immune effector cell patients. EClinicalMedicine. 2020;26.
16. Sanders RP, Maddirala SD, Geiger TL, Pounds S, Sandlund JT, Ribeiro RC, et al. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol. 2005;130(5):781–7.
17. Bahrami M, Felehkari F, Darvish-Khezri M, Kheirandish A, Mollaie A, Ahmadi M, et al. Prevalence of adverse transfusion reactions in hospitalized patients in tertiary heart center of Sari, Iran in 2014-2020. Tabari Biomed Student Res J. 2022;4(2):17–22.
18. Gelaw Y, Woldu B, Melku M. Proportion of acute transfusion reaction and associated factors among adult transfused patients at felege hiwot compressive referral hospital, Bahir Dar, Northwest Ethiopia: a cross-sectional study. J Blood Med. 2020;227–36.
19. Grandi JL, Grell MC, Areco KCN, Barbosa DA. Hemovigilance: the experience of transfusion reaction reporting in a Teaching Hospital. Rev da Esc Enferm da USP. 2018;52:e03331.
20. Malvik N, Leon J, Schlueter AJ, Wu C, Knudson CM. ABO‐incompatible platelets are associated with increased transfusion reaction rates. Transfusion. 2020;60(2):285–93.
21. Raval JS, Griggs JR, Fleg A. Blood product transfusion in adults: indications, adverse reactions, and modifications. 2020;102(1):30–8.
22. Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, et al. Red blood cell transfusion: 2023 AABB international guidelines. Jama. 2023;330(19):1892–902.
23. Rezende SM, Neumann I, Angchaisuksiri P, Awodu O, Boban A, Cuker A, et al. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology. J Thromb Haemost. 2024;22(9):2629–52.
24. Farmakis D, Porter J, Taher A, Cappellini MD, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation guidelines for the management of transfusion-dependent thalassemia. Hemasphere. 2022;6(8):e732.
25. Geiger TL, Howard SC. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev. 2007;21(1):1–12.
26. Rout P, Harewood J, Ramsey A, Master SR. Hemolytic Transfusion Reaction. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.
27. Kementrian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 91 Tahun 2015 Tentang Standar Pelayanan Transfusi Darah. Etika Jurnalisme Pada Koran Kuning : Sebuah Studi Mengenai Koran Lampu Hijau 2015 p. 39–55.
28. Fujiwara S, Kino S, Tanaka A, Hasegawa Y, Yokohama A, Fujino K, et al. A national survey of premedication for transfusion reactions in Japan. Transfus Apher Sci. 2017;56(5):708–12.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2025 Kemas Ya'kub Rahadiyanto, Desi Oktariana, Kemas Muhammad Alif (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
